跳至主要内容
临床试验/NCT00952796
NCT00952796已完成4 期

A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections

Kaohsiung Medical University Chung-Ho Memorial Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
100
试验地点
1
主要终点
clinical response at test-of-cure visit

研究概览

简要总结

On the basis of monotherapy for intra-abdominal infection, the investigators are conducting this study to identify the difference of drug efficacy between ampicillin/sulbactam and moxifloxacin.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • patients diagnosed of complicated intra-abdominal infection need surgical treatment

排除标准

  • patients diagnosed of intra-abdominal infection receive non-operative management
  • patients with known allergic history of fluoroquinolone
  • Severe, life threatening disease with a life expectancy of < 48 h or APS and APACHE scores of > 35

研究组 & 干预措施

1

Experimental

patients with intra-abdominal infection treated with moxifloxacin 400mg once daily

干预措施: moxifloxacin (Drug)

2

Active Comparator

patients with intra-abdominal infection treated with ampicillin/sulbactam 1.5g 4 times daily

干预措施: ampicillin/sulbactam (Drug)

结局指标

主要结局

clinical response at test-of-cure visit

时间窗: test of cure: 10-14 days after initial treatment

次要结局

未报告次要终点

研究者

研究点 (1)

Loading locations...

相似试验